Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy

NCT01838538 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer With Malignant Ascites

Interventions

DRUG: Bevacizumab
DRUG: TC:paclitaxel + carboplatin

Sponsor

Chinese PLA General Hospital